Shanghai, China

Weimin Liu

USPTO Granted Patents = 3 

Average Co-Inventor Count = 7.0

ph-index = 1


Company Filing History:


Years Active: 2022-2024

where 'Filed Patents' based on already Granted Patents

3 patents (USPTO):

Title: The Innovative Contributions of Weimin Liu in the Field of Peptide Compounds

Introduction: Weimin Liu, based in Shanghai, China, is a notable inventor recognized for his significant contributions in the realm of peptide compounds. With three patents to his name, Liu has demonstrated a profound commitment to advancing scientific knowledge and practical applications in pharmaceuticals.

Latest Patents: Liu's recent patents focus on the development of peptide compounds and their applications. One of his notable inventions includes a peptide compound referred to as YA-156, which, along with its pharmaceutically acceptable salts, tautomer, solvates, crystal forms, or prodrugs, exhibits remarkable stability and activity for Kiss1R. Another significant patent features a peptide compound represented by compound 3, offering similar desirable characteristics. Both inventions highlight Liu's innovative approach to developing compounds that could have impactful applications in medicine.

Career Highlights: Throughout his career, Weimin Liu has made substantial advances in his field, particularly during his tenure at prominent companies such as Xdcexplorer (Shanghai) Co., Ltd. and Shangpharma Innovation Inc. His work at these organizations has allowed him to hone his research skills and contribute to developing cutting-edge pharmaceutical solutions.

Collaborations: Liu's innovative journey has been enriched through his collaborations with esteemed colleagues, including Yvonne Angell and Yan Wang. Working alongside such talented individuals has fostered a dynamic exchange of ideas that has propelled their collective research efforts forward.

Conclusion: Weimin Liu's dedication to innovation through his patented peptide compounds showcases his pivotal role in advancing pharmaceutical science. His work not only highlights the potential of peptide-based therapies but also reflects the importance of collaboration in driving meaningful advancements in healthcare. As peptide compounds continue to gain traction in the industry, Liu's contributions will undoubtedly leave a lasting impact on the field.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…